| Q34525371 | A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection |
| Q45403934 | A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice |
| Q40365184 | A novel CD4-CD8alpha+CD205+CD11b- murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis |
| Q37333351 | A transmembrane domain-containing surface protein from Toxoplasma gondii augments replication in activated immune cells and establishment of a chronic infection |
| Q35102296 | ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18. |
| Q40707901 | Active cellular infection of myeloid cells is required for HIV-1-mediated suppression of interleukin-12 p40 expression |
| Q37056732 | Advances in the use of genetically engineered parasites to study immunity to Toxoplasma gondii |
| Q36310561 | Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP |
| Q44025765 | An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs |
| Q56880736 | CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells |
| Q35038836 | CD8 T Cells and Toxoplasma gondii: A New Paradigm |
| Q38461484 | CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection. |
| Q64898366 | CNBP controls IL-12 gene transcription and Th1 immunity. |
| Q40611245 | Cerebral Toxoplasmosis |
| Q40624199 | Characterisation of Toxoplasma gondii engineered to express mouse interferon-gamma |
| Q40997338 | Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii |
| Q85014576 | Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice |
| Q41808290 | Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii |
| Q54017156 | Cytokine and lymphocyte profiles in miniature swine after oral infection with Toxoplasma gondii oocysts. |
| Q36709991 | Cytokine regulation of immunopathology in toxoplasmosis |
| Q33775618 | Development of Neurological Mouse Model for Toxoplasmosis Using Toxoplasma gondii Isolated from Chicken in Kenya |
| Q21559499 | Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNgamma-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death |
| Q30541235 | Dynamics of T cell, antigen-presenting cell, and pathogen interactions during recall responses in the lymph node |
| Q44886868 | Effects of recent methyl mercury exposure on acute toxoplasmosis in CBA/J mice |
| Q47391375 | Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy. |
| Q92134784 | Evaluation of Immunogenic Effect of Toxoplasma gondii Recombinant SAG-1 Antigen with Propranolol as Adjuvant in BALB/c Mice |
| Q34388716 | Foxp4 is dispensable for T cell development, but required for robust recall responses |
| Q35594836 | From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii |
| Q57203114 | Functional characterization of in vivo effector CD4+ and CD8+ T cell responses in acute Toxoplasmosis: An interplay of IFN-γ and cytolytic T cells |
| Q57203120 | GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii |
| Q79166203 | Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies |
| Q36921649 | Genome-wide comparative analysis revealed significant transcriptome changes in mice after Toxoplasma gondii infection |
| Q34500617 | Host cell invasion by the opportunistic pathogen Toxoplasma gondii |
| Q36015869 | Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii |
| Q36625910 | IL-2 produced by CD8+ immune T cells can augment their IFN-γ production independently from their proliferation in the secondary response to an intracellular pathogen |
| Q37158941 | IL-7 and IL-15 do not synergize during CD8 T cell recall response against an obligate intracellular parasite |
| Q37158031 | Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. |
| Q46208643 | Immunological interaction between Giardia cyst extract and experimental toxoplasmosis. |
| Q39980904 | Immunopathology in ocular toxoplasmosis: facts and clues |
| Q36685549 | Impact of lipoxin-mediated regulation on immune response to infectious disease |
| Q37374700 | Improvement of a dendritic cell-based therapeutic cancer vaccine with components of Toxoplasma gondii |
| Q45069275 | In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting |
| Q35064310 | In the belly of the beast: subversion of macrophage proinflammatory signalling cascades during Toxoplasma gondii infection |
| Q34005898 | In vitro investigation of host resistance to Toxoplasma gondii infection in microglia of BALB/c and CBA/Ca mice |
| Q28586576 | Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection |
| Q46559948 | Inhibitory effects of a fermented ginseng extract, BST204, on the expression of inducible nitric oxide synthase and nitric oxide production in lipopolysaccharide-activated murine macrophages |
| Q33287802 | Interleukin-10 plays an early role in generating virus-specific T cell anergy |
| Q36971309 | Invasion and intracellular survival by protozoan parasites |
| Q37995683 | IκB kinase regulation of the TPL-2/ERK MAPK pathway |
| Q34597905 | Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite |
| Q43271653 | Lack of association between endothelial constitutive nitric oxide synthase (ecNOS 4 b/a) gene polymorphism and rheumatic heart disease |
| Q33792618 | Localized multigene expression patterns support an evolving Th1/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum |
| Q27348931 | MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis |
| Q36879444 | Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii |
| Q35884234 | Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signaling cascades during intracellular Toxoplasma gondii infection |
| Q64118852 | Maternal Immune Response During Pregnancy and Vertical Transmission in Human Toxoplasmosis |
| Q34130856 | Mechanism of entry determines the ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production |
| Q37577380 | Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly |
| Q45281820 | Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells |
| Q34065898 | Monocyte-mediated defense against microbial pathogens. |
| Q37764125 | Monocytes mediate mucosal immunity to Toxoplasma gondii |
| Q34342624 | Nitric oxide in parasitic infections |
| Q49486787 | Observations on bradyzoite biology |
| Q37402472 | Ocular toxoplasmosis: susceptibility in respect to the genes encoding the KIR receptors and their HLA class I ligands |
| Q36371418 | Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection |
| Q35139747 | Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes |
| Q34669530 | Proprotein convertase FURIN constrains Th2 differentiation and is critical for host resistance against Toxoplasma gondii. |
| Q49015701 | Protective Th1 immune responses against chronic toxoplasmosis induced by a protein-protein vaccine combination but not by its DNA-protein counterpart |
| Q43425324 | Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant |
| Q73256871 | Reciprocal regulation of polarized cytokine production by effector B and T cells |
| Q36403789 | Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis |
| Q28392677 | Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase |
| Q64096633 | Secretory Microneme Proteins Induce T-Cell Recall Responses in Mice Chronically Infected with Toxoplasma gondii |
| Q36580013 | Shared Immune and Repair Markers During Experimental Toxoplasma Chronic Brain Infection and Schizophrenia |
| Q40847688 | Suppression of inducible nitric oxide synthase expression in RAW 264. 7 macrophages by two beta-carboline alkaloids extracted from Melia azedarach |
| Q43753369 | Tachyzoite-specific isoform of Toxoplasma gondii lactate dehydrogenase is the target antigen of a murine CD4(+) T-cell clone |
| Q34037687 | The extracellular matrix protein mindin as a novel adjuvant elicits stronger immune responses for rBAG1, rSRS4 and rSRS9 antigens of Toxoplasma gondii in BALB/c mice |
| Q34257220 | The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Stat1 dependent and requires expression in both hematopoietic and nonhematopoietic cellular compartments |
| Q35029729 | The immunology of parasite infections in immunocompromised hosts |
| Q28730911 | The myeloid receptor PILRβ mediates the balance of inflammatory responses through regulation of IL-27 production |
| Q27341809 | The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18 |
| Q34334173 | The protozoan Neospora caninum directly triggers bovine NK cells to produce gamma interferon and to kill infected fibroblasts |
| Q33631447 | The role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis |
| Q35951793 | The role of type I interferons in non-viral infections |
| Q41990258 | The roles of galectins in parasitic infections. |
| Q36041799 | The secreted kinase ROP18 defends Toxoplasma's border |
| Q33606707 | The unexpected role for the aryl hydrocarbon receptor on susceptibility to experimental toxoplasmosis |
| Q34376021 | Toxoplasma gondii and MHC-restricted antigen presentation: on degradation, transport and modulation |
| Q40725983 | Toxoplasma gondii infection can regulate the expression of tumour necrosis factor-alpha receptors on human cells in vitro |
| Q35088408 | Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity |
| Q34721141 | Toxoplasma gondii inhibits toll-like receptor 4 ligand-induced mobilization of intracellular tumor necrosis factor alpha to the surface of mouse peritoneal neutrophils |
| Q30411019 | Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria |
| Q39654386 | Toxoplasma gondii-infected human myeloid dendritic cells induce T-lymphocyte dysfunction and contact-dependent apoptosis |
| Q24655428 | Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii |
| Q93115962 | Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases |
| Q33600405 | Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans |
| Q34280074 | Tumour necrosis factor alpha receptors: role in the physiopathology of protozoan parasite infections |
| Q35884184 | Turning it on and off: regulation of dendritic cell function in Toxoplasma gondii infection |